Procter & Gamble is entering fiscal 2027 focused on balancing pricing with volume growth after organic sales rose 1% in fiscal 2026, with pricing contributing one point and volume up modestly for the year. Momentum was limited in the fourth quarter, when volume rounded down to flat and pricing and mix were neutral. Management expects promotions to move toward pre-pandemic levels while continuing to drive price/mix, aiming for a more balanced contribution from volume, price and mix in fiscal 2027. The Zacks Consensus Estimate for PG's fiscal 2027 and fiscal 2028 earnings per share indicates year-over-year growth of 1.5% and 6.2%, respectively, with the fiscal 2027 estimate moving lower and the fiscal 2028 estimate stable over the past 30 days. PG shares have gained 3% in the past six months compared with the industry's 2% growth, and the stock trades at a forward price-to-earnings ratio of 20.67X versus the industry average of 18.25X. Procter & Gamble currently carries a Zacks Rank #3 (Hold).
Procter & Gamble CompanyP&G's fiscal 2026 organic sales rose 1% with pricing contributing one point, but Q4 volume was flat and management aims for more balanced volume/price/mix in fiscal 2027.
The Clorox Company